Suppr超能文献

糖尿病肾病患者血液透析期间低血糖风险临床自动计算方法的开发。

Development of a clinical automatic calculation of hypoglycemia during hemodialysis risk in patients with diabetic nephropathy.

作者信息

Zhang Rui-Ting, Liu Yu, Lin Ke-Ke, Jia Wan-Ning, Wu Quan-Ying, Wang Jing, Bai Xiao-Yan

机构信息

School of Nursing, Beijing University of Chinese Medicine, Beijing, China.

Blood Purification Center of China-Japan Friendship Hospital, Beijing, China.

出版信息

Diabetol Metab Syndr. 2023 Oct 13;15(1):199. doi: 10.1186/s13098-023-01177-9.

Abstract

BACKGROUND

Hypoglycemia is one of the most common complications in patients with DN during hemodialysis. The purpose of the study is to construct a clinical automatic calculation to predict risk of hypoglycemia during hemodialysis for patients with diabetic nephropathy.

METHODS

In this cross-sectional study, patients provided information for the questionnaire and received blood glucose tests during hemodialysis. The data were analyzed with logistic regression and then an automated calculator for risk prediction was constructed based on the results. From May to November 2022, 207 hemodialysis patients with diabetes nephropathy were recruited. Patients were recruited at blood purifying facilities at two hospitals in Beijing and Inner Mongolia province, China. Hypoglycemia is defined according to the standards of medical care in diabetes issued by ADA (2021). The blood glucose meter was used uniformly for blood glucose tests 15 minutes before the end of hemodialysis or when the patient did not feel well during hemodialysis.

RESULTS

The incidence of hypoglycemia during hemodialysis was 50.2% (104/207). The risk prediction model included 6 predictors, and was constructed as follows: Logit (P) = 1.505×hemodialysis duration 815 years (OR = 4.506, 3 points) + 1.616×hemodialysis duration 1621 years (OR = 5.032, 3 points) + 1.504×having hypotension during last hemodialysis (OR = 4.501, 3 points) + 0.788×having hyperglycemia during the latest hemodialysis night (OR = 2.199, 2 points) + 0.91×disturbance of potassium metabolism (OR = 2.484, 2 points) + 2.636×serum albumin<35 g/L (OR = 13.963, 5 points)-4.314. The AUC of the prediction model was 0.866, with Matthews correlation coefficient (MCC) of 0.633, and Hosmer-Lemeshow χ of 4.447(P = 0.815). The automatic calculation has a total of 18 points and four risk levels.

CONCLUSIONS

The incidence of hypoglycemia during hemodialysis is high in patients with DN. The risk prediction model in this study had a good prediction outcome. The hypoglycemia prediction automatic calculation that was developed using this model can be used to predict the risk of hypoglycemia in DN patients during hemodialysis and also help identify those with a high risk of hypoglycemia during hemodialysis.

摘要

背景

低血糖是糖尿病肾病患者血液透析期间最常见的并发症之一。本研究的目的是构建一种临床自动计算方法,以预测糖尿病肾病患者血液透析期间的低血糖风险。

方法

在这项横断面研究中,患者填写问卷信息并在血液透析期间接受血糖检测。对数据进行逻辑回归分析,然后根据结果构建风险预测自动计算器。2022年5月至11月,招募了207例糖尿病肾病血液透析患者。患者来自中国北京和内蒙古自治区两家医院的血液净化机构。低血糖根据美国糖尿病协会(2021年)发布的糖尿病医疗护理标准定义。在血液透析结束前15分钟或患者在血液透析期间感觉不适时,统一使用血糖仪进行血糖检测。

结果

血液透析期间低血糖的发生率为50.2%(104/207)。风险预测模型包括6个预测因素,构建如下:Logit(P)=1.505×血液透析时长8至15年(OR=4.506,3分)+1.616×血液透析时长16至21年(OR=5.032,3分)+1.504×上一次血液透析期间有低血压(OR=4.501,3分)+0.788×最近一次血液透析夜间有高血糖(OR=2.199,2分)+0.91×钾代谢紊乱(OR=2.484,2分)+2.636×血清白蛋白<35g/L(OR=13.963,5分)-4.314。预测模型的AUC为0.866,马修斯相关系数(MCC)为0.633,Hosmer-Lemeshow χ为4.447(P=0.815)。该自动计算方法共有18分和四个风险等级。

结论

糖尿病肾病患者血液透析期间低血糖的发生率较高。本研究中的风险预测模型具有良好的预测效果。使用该模型开发的低血糖预测自动计算方法可用于预测糖尿病肾病患者血液透析期间的低血糖风险,也有助于识别血液透析期间低血糖风险较高的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c2e/10571353/1c118a36c330/13098_2023_1177_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验